ARTICLE | Company News
Alliance Pharma, Novartis sales and marketing update
June 17, 2013 7:00 AM UTC
Alliance's Alliance Pharmaceuticals Ltd. subsidiary acquired all rights to Syntometrine oxytocin/ergometrine from Novartis for $11.5 million. Alliance already had rights to the product in the U.K. und...